Update from PSMA-SRT Trial NCT03582774: A Randomized Phase 3 Imaging Trial of Prostate-specific Membrane Antigen Positron Emission Tomography for Salvage Radiation Therapy for Prostate Cancer Recurrence Powered for Clinical Outcome

Eur Urol Focus. 2020 Dec 29:S2405-4569(20)30311-4. doi: 10.1016/j.euf.2020.12.009. Online ahead of print.


The purpose of this randomized trial is to evaluate the success rate of salvage radiation therapy for recurrence of prostate cancer after radical prostatectomy, with and without planning based on prostate-specific membrane antigen positron emission tomography/computed tomography. Enrollment has been completed and patients are being followed for 5yr.

PMID:33386288 | DOI:10.1016/j.euf.2020.12.009